61
Hans Peter Haar, Gerhard Werner, Dirk Boecker, Armin Lambrecht, Joachim Kastner: Analytical device for in vivo analysis in the body of a patient. Roche Diagnostics, Jill L Woodburn, June 24, 2003: US06584335 (237 worldwide citation)

Analysis device for determining an analyte in vivo in the body of a patient, having a measuring probe with a hollow needle (


62
Robert R Steuer, David R Miller: Method and apparatus for non-invasive blood constituent monitoring. In Line Diagnostics Corporation, Jacobson Price Holman & Stern PLLC, January 30, 2001: US06181958 (236 worldwide citation)

A system for determining a biologic constituent including hematocrit transcutaneously, noninvasively and continuously. A finger clip assembly includes including at least a pair of emitters and a photodiode in appropriate alignment to enable operation in either a transmissive mode or a reflectance mo ...


63
Joel S Douglas, Jeffrey N Roe, Ryszard Radwanski, Brent G Duchon, Michael J Sanchez, Henry M Grage: Disposable element for use in a body fluid sampling device. Mercury Diagnostics, Burns Doane Swecker & Mathis L, April 11, 2000: US06048352 (235 worldwide citation)

A disposable lancing element is adapted for use in a lancing device for making an incision through a user's skin. The lancing element includes a body which defines a longitudinal axis, and has a skin-lancing member projecting from a front end thereof. A capillary tube is mounted in the body in later ...


64
Robert J Nelson, Herbert H Hooper, Alan K Hauser, Sharat Singh, Stephen J Williams, Alexander P Sassi: Microfluidic method for nucleic acid purification and processing. ACLARA Biosciences, Bertram I Rae Venter Law Group P C Rowland, June 13, 2000: US06074827 (235 worldwide citation)

Integrated microfluidic devices comprising at least an enrichment channel and a main electrophoretic flowpath are provided. In the subject integrated devices, the enrichment channel and the main electrophoretic flowpath are positioned so that waste fluid flows away from said main electrophoretic flo ...


65
Gary T Neel, Douglas E Bell, T Philip Wong, Houston F Voss, Allan Javier Caban, David K Boehm: Systems and methods for blood glucose sensing. Home Diagnostics, Finnegan Henderson Farabow Garrett & Dunner L, September 20, 2005: US06946299 (234 worldwide citation)

A system for measuring a glucose level in a blood sample includes a test strip and a meter. The test strip includes a sample chamber, a working electrode, a counter electrode, fill-detect electrodes, and an auto-on conductor. A reagent layer is disposed in the sample chamber. The auto-on conductor c ...


66
Raghbir S Bhullar, Henning Groll, John T Austera, Douglas P Walling, Timothy I Ranney, James L Pauley Jr: Biosensor with code pattern. Roche Diagnostics Corporation, Jill L Woodburn, November 9, 2004: US06814844 (234 worldwide citation)

The present invention relates to a biosensor. The biosensor includes a support substate, an electrically conductive coating positioned on the support substrate, the coating being formed to define electrodes and a code pattern, wherein there is sufficient contrast between the conductive coating and t ...


67
Stanley T Crooke: Oligoribonucleotides for cleaving RNA. ISIS Pharmaceuticals, Woodcock Washburn Kurtz Mackiewicz & Norris, April 27, 1999: US05898031 (231 worldwide citation)

Oligomeric compounds including oligoribonucleotides and oligoribonucleosides are provided that have subsequences of 2-pentoribofuranosyl nucleosides that activate dsRNase. The oligoribonucleotides and oligoribonucleosides can include substituent groups for increasing binding affinity to complementar ...


68
Graham Beaton, Eric F Fisher: Modified oligonucleotides and intermediates useful in nucleic acid therapeutics. Amgen, Ron K Levy, Steven M Odre, April 29, 1997: US05625050 (231 worldwide citation)

The present invention provides nuclease resistant 3'-carbon modified oligonucleotides that can be used in the field of nucleic acid therapeutics and diagnostics. The modified oligonucleotides of the present invention have at least one modified internucleotide linkage wherein the divalent oxygen moie ...


69
Phillip D Cook, Gerhard Baschang: Cyclobutyl oligonucleotide surrogates. ISIS Pharmaceuticals, Ciba-Geigy, Woodcock Washburn Kurtz Mackiewicz & Norris, October 25, 1994: US05359044 (230 worldwide citation)

Oligonucleotide surrogates comprising a plurality of cyclobutyl moieties covalently joined by linking moieties are prepared and used as antisense diagnostics and research reagents. Methods of synthesis and use of both the oligonucleotide surrogates and intermediates thereof are disclosed.


70
Elizabeth A Cummings, Mary E McEvoy, Lars H Berger, Ulrich Kraft, Rainer R Teucher, John C Davis: Analyte testing device. Diabetes Diagnostics, Bernard E Shay, July 10, 2007: US07241265 (229 worldwide citation)

The present invention is a testing device for testing analyte levels in bodily fluids. The testing device comprises memory (202) for storing data, said data being analyte data related to analyte measurements carried out by the meter and lifestyle data; initiation means (102) for initiating immediate ...



Click the thumbnails below to visualize the patent trend.